FEBS Letters 1998-07-24

Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.

C J Hastie, P T Cohen

Index: FEBS Lett. 431 , 357-361, (1998)

Full Text: HTML

Abstract

Protein phosphatase 4 (PP4) is a protein serine/threonine phosphatase that predominantly localises to centrosomes and plays a role in microtubule organisation at centrosomes. Here, PP4 catalytic subunit has been purified from porcine testis to near homogeneity and a specific activity of 680 mU/mg against phosphorylase alpha. The antitumour drug, fostriecin, inhibits PP4 catalytic subunit (IC50 3 nM) with similar potency to PP2A catalytic subunit (IC50 1.5 nM). PP4 is also inhibited in the nanomolar range by several naturally occurring tumour promoters and toxins, with similar IC50 values to those obtained for PP2A. The gene for human PP4 catalytic subunit localises to 16p11.2.


Related Compounds

Related Articles:

Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae.

2011-04-06

[J. Neurosci. 31 , 5512-25, (2011)]

Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.

1998-08-15

[Cancer Res. 58 , 3611-3619, (1998)]

Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.

1997-10-27

[FEBS Lett. 416 , 230, (1997)]

Novel antitumor agents CI-920, PD 113,270 and PD 113,271. II. Isolation and characterization.

1983-12-01

[J. Antibiot. 36 , 160-1605, (1983)]

Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties.

1983-12-01

[J. Antibiot. 36 , 1595-1600, (1983)]

More Articles...